Close

Analyst Ratings for Cyclo Therapeutics (CYTH)

CYTH Rating Summary

  |   Expand Research on CYTH
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 0 / 10
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/20/2023 Maxim Group Jason McCarthy Downgrade Hold
(Buy)		 N/A
(N/A)		 1.11
(1.28)		 15.32% Details
Like CYTH Ratings? Also take a look at CNSP, SURG, AREC, AEZS

CYTH Ratings News